TRGM - Targeted Medical Pharma, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201512/31/201412/31/201312/31/2012
Total Revenue5,260.9417,112.3599,555.5627,296.401
Cost of Revenue2,095.6812,216.5282,989.3053,201.391
Gross Profit3,165.264,895.8316,566.2574,095.01
Operating Expenses
Research Development12.317158.37228.605133.84
Selling General and Administrative5,043.3987,348.4129,771.59810,100.979
Non Recurring----
Others----
Total Operating Expenses7,151.3969,723.3112,989.50813,436.21
Operating Income or Loss-1,890.455-2,610.951-3,433.946-6,139.809
Income from Continuing Operations
Total Other Income/Expenses Net-1,176.737-1,218.23-236.77-6,632.311
Earnings Before Interest and Taxes-1,890.455-2,610.951-3,433.946-6,139.809
Interest Expense-1,173.565-1,229.289-559.257-2,260.045
Income Before Tax-3,067.192-3,829.181-3,670.716-12,772.12
Income Tax Expense-65.8285,666.902-3,185.938
Minority Interest-23.382-23.382-23.382-23.382
Net Income From Continuing Ops-3,067.192-3,895.009-9,337.618-9,586.182
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-3,043.81-3,895.009-9,337.618-9,586.182
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-3,043.81-3,895.009-9,337.618-9,586.182